“ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment,” Journal of Clinical Child & Adolescent Psychology, May 22, 2024.
“The DEA is investigating Cerebral as the $4.8 billion mental-health startup faces growing scrutiny,” Business Insider, May 4, 2022.
“Ex-Cerebral executive files lawsuit claiming the startup over prescribed ADHD meds,” Fierce Healthcare, April 29, 2022.
“‘Falling through the cracks’: Why ADHD is under-diagnosed among Asian Americans,” STAT News, June 19, 2023.
“For Some Women With ADHD, TikTok Is the First Place They Felt Heard,” TIME, September 12, 2022.
“Genome-wide analyses of ADHD identify 27 risk loci,” Nature Genetics, 2023.
“The Hazards of Prescribing A.D.H.D. Drugs Online,” The New York Times, May 8, 2022.
“Number of ADHD Patients Rising, Especially Among Women,” Epic Research, March 30, 2023.
“Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort,” JAMA, 2021.
“Startup Cerebral Soared on Easy Adderall Prescriptions. That Was Its Undoing,” The Wall Street Journal, June 8, 2022.
“Stimulant Prescription Trends in the United States From 2012-2022,” IQVIA Report, August 31, 2023.
“TikTok and Attention-Deficit/Hyperactivity Disorder: A Cross-Sectional Study of Social Media Content Quality,” The Canadian Journal of Psychiatry, 2022.